Tag: Switzerland

The ‘Innovation of the Year’ fundraising award was presented in recognition of the Swiss MS Society’s 2017 World MS Day event, ‘We send a signal’.

The EMA has recommended that ocrelizumab (Ocrevus), the first disease-modifying treatment for primary progressive MS (PPMS), be prescribed for adults with early primary progressive MS

A flavour of how global MS organisations marked World MS Day 2017

Training programme led to significant improvements in manual dexterity